ID
CRI icon

Integral Derivatives’s Carter's CRI Stock Holding History

Integral Derivatives’s Portfolio CRI Stock Details CRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-2,800
Closed -$217K – 1388
2014
Q3 		$217K Buy
+2,800
New +$216K ﹤0.01% 1254

Other funds holding CRI

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Integral Derivatives's CRI Position: Q4 2014 in Review

Integral Derivatives sold out of Carter's (CRI) in Q4 2014, closing a stake of 2,800 shares — an estimated $217K sold.

Integral Derivatives first reported a position in CRI in Q3 2014 and held it in 1 quarter. The position peaked at $217K in Q3 2014. 251 funds tracked by Wall St. Rank hold CRI as of Q4 2014.

  • Integral Derivatives reported no remaining Carter's position as of Q4 2014 after selling out during the quarter.
  • Integral Derivatives sold 2,800 Carter's shares in Q4 2014, an estimated $217K.
  • Integral Derivatives first reported a position in Carter's in Q3 2014 and held it in 1 quarter.
  • Integral Derivatives's Carter's position peaked at $217K in Q3 2014.
  • 251 funds tracked by Wall St. Rank held Carter's as of Q4 2014.

Based on Integral Derivatives's 13F filing for Q4 2014, filed 11 Feb 2015.